← Back to Illumina Ventures profile
Illumina Ventures related stories
All articles and analysis
Illumina Ventures collects $230 mln for maiden fundSan Francisco-based Illumina Ventures, an early-stage venture firm, has raised $230 million for its debut fund. Illumina invests in early-stage companies focused on genomics and precision medicine.
- DNA Script takes in Series A
Paris-based DNA Script, a synthetic DNA manufacturer, has raised 11 million euros in Series A funding. The investors were Sofinnova Partners, Kurma Partners, Idinvest Partners, Illumina Ventures and Merck Ventures BV.
- Illumina raises $189 mln toward expanded venture fund
Illumina has more than doubled the size of its venture fund and raised $189 million toward the $250 million target, according to a filing with the SEC.